Page 1,164«..1020..1,1631,1641,1651,166..1,1701,180..»

Joel Arun Sursas Shares How to Enhance the Patient Experience with Technology – iTech Post

Posted: Published on December 18th, 2019

Tech (Photo : photo) Nearly every person dreads going to the doctor. Often people avoid seeking medical attention because of a bad experience due to a lack of communication or outdated equipment and technology. However, this can put patients at risk for letting undiagnosed issues wreak irreversible and/or costly havoc on their bodies Continue reading

Posted in Medical Technology | Comments Off on Joel Arun Sursas Shares How to Enhance the Patient Experience with Technology – iTech Post

Medical Record Review Technology Platform Adds Module for Itemized Bill Reviews And Expands Search Tool with Clinical Terms and Drug Names -…

Posted: Published on December 18th, 2019

NASHVILLE, Tenn., Dec.17, 2019 /PRNewswire/ --Advent Health Partners, Inc. has unveiled an additional module for the CAVO medical record review technology platform that intakes itemized bills (IBs) and auto-converts them into sortable and filterable data. Instead of sifting through information within PDFs, reviewers easily find information, make accept/reject decisions by line, and utilize real-time, auto-summed totals for adjustments and charges Continue reading

Posted in Medical Technology | Comments Off on Medical Record Review Technology Platform Adds Module for Itemized Bill Reviews And Expands Search Tool with Clinical Terms and Drug Names -…

AWAK Technologies Raises US$40 Million to Ready AWAK PD Wearable Dialysis Device for Late-Stage Development and Accelerated Commercialisation -…

Posted: Published on December 18th, 2019

December 12, 2019 20:00 ET | Source: AWAK Technologies photo-release AWAK Peritoneal Dialysis (AWAK PD) device Singapore, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Singapore, 13 December 2019 AWAK Technologies (AWAK), a pioneering medical technology company focused on dialysis using regeneration technology for end-stage kidney disease, today announced it has raised US$40 million of new funds in an oversubscribed financing round to ready its wearable and ultra-portable AWAK Peritoneal Dialysis (AWAK PD) device for late-stage clinical studies and accelerate its commercialisation plans. Continue reading

Posted in Medical Technology | Comments Off on AWAK Technologies Raises US$40 Million to Ready AWAK PD Wearable Dialysis Device for Late-Stage Development and Accelerated Commercialisation -…

Philips to nominate Feike Sijbesma and Peter Lscher as members of the Supervisory Board – GlobeNewswire

Posted: Published on December 18th, 2019

December 17, 2019 02:00 ET | Source: Royal Philips photo-release December 17, 2019 Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it will propose the appointments of Feike Sijbesma and Peter Lscher as new members of the Supervisory Board to the Annual General Meeting of Shareholders (AGM), which will be held on April 30, 2020. We are pleased that Feike Sijbesma and Peter Lscher are available to join Philips Supervisory Board, said Jeroen van der Veer, Chairman of the Supervisory Board of Royal Philips. Mr. Continue reading

Posted in Medical Technology | Comments Off on Philips to nominate Feike Sijbesma and Peter Lscher as members of the Supervisory Board – GlobeNewswire

What’s So Trendy about Medical Beds Market That Everyone Went Crazy over It? | Arjo., Hill-Rom Sercices, Inc, Paramount Bed Co. Ltd, Invacare…

Posted: Published on December 18th, 2019

In terms of revenue, Global medical beds market was valued at US$ 2978.0 million in 2018 and is anticipated to reach US$ 4750.0 million by 2027, growing at a CAGR of 5.3% over the forecast period. Continue reading

Posted in Medical Technology | Comments Off on What’s So Trendy about Medical Beds Market That Everyone Went Crazy over It? | Arjo., Hill-Rom Sercices, Inc, Paramount Bed Co. Ltd, Invacare…

Nexstim Plc’s Board of Directors resolved on a directed share issue of approximately 141 thousand euro to Kreos Capital V (UK) Limited – GlobeNewswire

Posted: Published on December 18th, 2019

December 18, 2019 02:00 ET | Source: Nexstim Oyj multilang-release Company announcement, insider information, Helsinki, 18 December 2019 at 9.00 am (EET) Nexstim Plcs Board of Directors resolved on a directed share issue of approximately 141 thousand euro to Kreos Capital V (UK) Limited The Board of Directors of Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") has resolved on a directed share issue in which in total 1,186,718 new shares of the Company are issued to Kreos Capital V (UK) Limited (Kreos) against a subscription price of EUR 0.119 per share on terms that the aggregate subscription price of such new shares EUR 141,219.44 shall be paid by setting-off the loan receivable of Kreos against the Company. In accordance with a company announcement dated 13 September 2019, Kreos and the Company have on such date entered into an agreement regarding additional voluntary loan repayments Continue reading

Posted in Medical Technology | Comments Off on Nexstim Plc’s Board of Directors resolved on a directed share issue of approximately 141 thousand euro to Kreos Capital V (UK) Limited – GlobeNewswire

How The Symptoms Of Perimenopause Sneak Up On Women & How To Deal With Irregular Periods, Heavy Bleeding And Hot Flashes – YourTango

Posted: Published on December 16th, 2019

Why are we so secretive about this normal part of aging? Perimenopause hit me like a ton of bricks. One month, everything was steady and predictable. Continue reading

Posted in Hormone Replacement Therapy | Comments Off on How The Symptoms Of Perimenopause Sneak Up On Women & How To Deal With Irregular Periods, Heavy Bleeding And Hot Flashes – YourTango

Hormone Replacement Therapy (HRT) Market: Regional Industry Segmentation, Analysis by Production, Consumption, Revenue and Growth Rate by 2024 – Hitz…

Posted: Published on December 16th, 2019

TheHormone Replacement Therapy (HRT) MarketReport provides a 360-degree holistic view of the market and highlights the key developments, drivers, restraints, growth factors, opportunities and Strategic trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast phase 2020-2024. In addition, the Hormone Replacement Therapy (HRT) report also provides profiles of major companies along with exhaustive SWOT analysis, financial facts and key developments of products/services from the past five years. TheCompany Coverageof Hormone Replacement Therapy (HRT) market is as per below (Sales Revenue, Price, Gross Margin, Main Products etc): [FREE OF COST] Get Sample Copy of the Hormone Replacement Therapy (HRT) Market Report: https://www.esherpamarketreports.com/request-sample/es-11222/ Target Audience of Hormone Replacement Therapy (HRT) Market 2020 Forecast to 2024 Market: The content of the study subjects, includes a total of 15 chapters: Enquire more or share questions if any before the purchase on Hormone Replacement Therapy (HRT) report https://www.esherpamarketreports.com/pre-order-enquiry/es-11222/ On the basis of the end users/applications, this Hormone Replacement Therapy (HRT) market report focuses on the status and outlook for major applications/end users, consumption (sales), Hormone Replacement Therapy (HRT) industry share and growth rate for each application, including: On the basis of product, this report displays the production, revenue, price, Hormone Replacement Therapy (HRT) market share and growth rate of each type, primarily split into: Hormone Replacement Therapy (HRT) Market 2020 Forecast to 2024Market Segment by Regions, regional analysis covers Reasons to buy Hormone Replacement Therapy (HRT) Market Report: Purchase Hormone Replacement Therapy (HRT) Market Report https://www.esherpamarketreports.com/purchase/es-11222/ This Hormone Replacement Therapy (HRT) Market Research/analysis Report Contains Answers to your following questions About Us: Esherpa Market Reports is the credible source for gaining the market research reports that will exponentially accelerate your business Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Hormone Replacement Therapy (HRT) Market: Regional Industry Segmentation, Analysis by Production, Consumption, Revenue and Growth Rate by 2024 – Hitz…

Hormonal therapy for patients with breast, gynecologic cancer – Contemporary Obgyn

Posted: Published on December 16th, 2019

A literature search has found that the role of hormone therapy (HT) in menopausal patients with breast cancer and gynecologic malignancies is a mixed bag. Systemic HT is not recommended for breast cancer survivors, according to the results in the journal Menopause, but vaginal low-dose estrogen appears safe. In addition, HT can be used to treat endometrial, cervical and ovarian cancer in patients with low-risk, non-estrogen-receptor-positive subtypes. Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Hormonal therapy for patients with breast, gynecologic cancer – Contemporary Obgyn

PPI Use and Periodontal Disease: What’s the Link? – MPR – Monthly Prescribing Reference

Posted: Published on December 16th, 2019

The use of proton pump inhibitors (PPIs) in patients with generalized, chronic, moderate-to-severe periodontitis (stage III to IV; grade B to C) was associated with less severe periodontitis, according to study findings presented at the 2019 AIBD Annual Meeting in Orlando, Florida. For this study, researchers aimed to assess whether treatment with a PPI could potentially decrease bone loss in patients with periodontitis Continue reading

Posted in Hormone Replacement Therapy | Comments Off on PPI Use and Periodontal Disease: What’s the Link? – MPR – Monthly Prescribing Reference

Page 1,164«..1020..1,1631,1641,1651,166..1,1701,180..»